Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Thursday, BidAskClub rep
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE